Assessment of nutritional risks of special diets and drugs used in the management of familial hypercholesterolemia.
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000009:adverse effects*; D001647:Bile Acids and Salts / Q000378:metabolism; D002792:Cholestyramine Resin / Q000009:adverse effects; D002994:Clofibrate / Q000009:adverse effects; D003084:Colestipol / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D005685:Galactans / Q000009:adverse effects; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000178:diet therapy / Q000628:therapy*; D008297:Male; D008351:Mannans / Q000009:adverse effects; D008875:Middle Aged; D009355:Neomycin / Q000009:adverse effects; D009747:Nutritional Physiological Phenomena; D053149:Plant Gums; D014674:Plant Proteins, Dietary / Q000009:adverse effects; D011341:Probucol / Q000009:adverse effects; D012306:Risk; D030262:Soybean Proteins
D000924:Anticholesteremic Agents; D001647:Bile Acids and Salts; D005685:Galactans; D008351:Mannans; D053149:Plant Gums; D014674:Plant Proteins, Dietary; D030262:Soybean Proteins; D002792:Cholestyramine Resin; C007894:guar gum; D002994:Clofibrate; D009355:Neomycin; D003084:Colestipol; D011341:Probucol